Spark Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Spark Investment Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-30,000	Closed	-$57K	–	762
2018 Q2	$57K	Buy	+30,000	New	+$60.6K	﹤0.01%	633
2016 Q3	–	Sell	-53,700	Closed	-$71K	–	907
2016 Q2	$71K	Buy	+53,700	New	+$251K	0.01%	730

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Spark Investment Management's INFI Position: Q3 2018 in Review

Spark Investment Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2018, closing a stake of 30,000 shares — an estimated $57K sold.

Spark Investment Management first reported a position in INFI in Q2 2016 and held it in 2 quarters. The position peaked at $71K in Q2 2016. 63 funds tracked by Wall St. Rank hold INFI as of Q3 2018.

Spark Investment Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
Spark Investment Management sold 30,000 Infinity Pharmaceuticals, Inc. shares in Q3 2018, an estimated $57K.
Spark Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2016 and held it in 2 quarters.
Spark Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $71K in Q2 2016.
63 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2018.

Based on Spark Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.